198 related articles for article (PubMed ID: 21944671)
41. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
Hamilton SJ; Chew GT; Davis TM; Watts GF
Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
[TBL] [Abstract][Full Text] [Related]
42. Insulin and non-insulin mediated vasodilation and glucose uptake in patients with type 2 diabetes.
Scheede-Bergdahl C; Olsen DB; Reving D; Boushel R; Dela F
Diabetes Res Clin Pract; 2009 Sep; 85(3):243-51. PubMed ID: 19640601
[TBL] [Abstract][Full Text] [Related]
43. Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia.
Arora S; Lidor A; Abularrage CJ; Weiswasser JM; Nylen E; Kellicut D; Sidawy AN
Ann Vasc Surg; 2006 Sep; 20(5):653-8. PubMed ID: 16741654
[TBL] [Abstract][Full Text] [Related]
44. Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
Lai J; Wu B; Sun J; Shang Y; Zhu J
Coron Artery Dis; 2013 Nov; 24(7):566-71. PubMed ID: 23994882
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and Safety of Miglitol- or Repaglinide-Based Combination Therapy with Alogliptin for Drug-Naïve Patients with Type 2 Diabetes: An Open-Label, Single-Center, Parallel, Randomized Controlled Pilot Study.
Okajima F; Sugihara H; Emoto N
J Nippon Med Sch; 2021 Mar; 88(1):71-79. PubMed ID: 32475902
[TBL] [Abstract][Full Text] [Related]
46. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
Antoniades C; Tousoulis D; Marinou K; Papageorgiou N; Bosinakou E; Tsioufis C; Stefanadi E; Latsios G; Tentolouris C; Siasos G; Stefanadis C
Clin Cardiol; 2007 Jun; 30(6):295-300. PubMed ID: 17551966
[TBL] [Abstract][Full Text] [Related]
47. The relation of HOMA index with endothelial functions determined by flow mediated dilatation method among hyperglycemic patients.
Karabağ T; Kaya A; Yavuz S; Kaya C; Koc F; Yeter E
Indian Heart J; 2007; 59(6):463-7. PubMed ID: 19151460
[TBL] [Abstract][Full Text] [Related]
48. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.
Chen S; Shen Y; Liu YH; Dai Y; Wu ZM; Wang XQ; Yang CD; Li LY; Liu JM; Zhang LP; Shen WF; Ji R; Lu L; Ding FH
Cardiovasc Diabetol; 2021 Mar; 20(1):64. PubMed ID: 33714276
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
Singh KP; Periyandavar I; Rajadhyaksha GC; Jayaram S; Mishra AB; Kinagi S; Sharma A; Baliga VP
J Indian Med Assoc; 2007 Jun; 105(6):344, 346, 350. PubMed ID: 18232183
[TBL] [Abstract][Full Text] [Related]
50. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
Johnson AB; Taylor R
Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
[TBL] [Abstract][Full Text] [Related]
51. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Hamada Y; Nagasaki H; Fuchigami M; Furuta S; Seino Y; Nakamura J; Oiso Y
Metabolism; 2013 May; 62(5):734-42. PubMed ID: 23194643
[TBL] [Abstract][Full Text] [Related]
52. Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study.
Leung M; Leung DY; Wong VW
Diab Vasc Dis Res; 2016 May; 13(3):236-43. PubMed ID: 26993495
[TBL] [Abstract][Full Text] [Related]
53. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
[TBL] [Abstract][Full Text] [Related]
54. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones.
Aoki K; Sato H; Terauchi Y
Endocr J; 2019 May; 66(5):395-401. PubMed ID: 31019154
[TBL] [Abstract][Full Text] [Related]
56. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
[TBL] [Abstract][Full Text] [Related]
57. Daily use of sildenafil improves endothelial function in men with type 2 diabetes.
Deyoung L; Chung E; Kovac JR; Romano W; Brock GB
J Androl; 2012; 33(2):176-80. PubMed ID: 21680809
[TBL] [Abstract][Full Text] [Related]
58. Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance.
Yokoyama H; Inoue T; Node K
Diabetes Res Clin Pract; 2009 Jan; 83(1):77-82. PubMed ID: 19027977
[TBL] [Abstract][Full Text] [Related]
59. Effect of miglitol administration to non-insulin-dependent diabetic rats.
Tormo MA; Ropero MF; Nieto M; Martinez IM; Campillo JE
Gen Pharmacol; 1998 Jan; 30(1):125-9. PubMed ID: 9457493
[TBL] [Abstract][Full Text] [Related]
60. Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.
Joubert PH; Foukaridis GN; Bopape ML
Eur J Clin Pharmacol; 1987; 31(6):723-4. PubMed ID: 3549325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
